PATENT CLAIM ANALYSIS

Application Number: 15751163
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["546", "115000"]

Abstract:
The invention relates to capthepsin K inhibitors and uses thereof, specifically relates to a class of compounds having the formula (I) which are used for treating or preventing cathepsin dependent diseases or conditions, specifically, wherein the cathepsin is capthepsin K. The compounds and compositions thereof can be used as bone resorption inhibitors for the treatment of associated diseases.

Claim (Index 12):
A method of treating, preventing, lessening or relieving osteoporosis, Paget's disease, abnormally increased bone turnover, periodontal disease, tooth loss, bone fractures, rheumatoid arthritis, osteoarthritis, periprosthetic osteolysis, osteogenesis imperfecta, metastatic bone disease, serious high calcium in blood, multiple myeloma, multiple sclerosis, myasthenia gravis, psoriasis, pemphigus vulgaris, exophthalmic goiter, systemic lupus erythematosus, asthma, pain, atherosclerosis, bone loss, abnormally increased bone turnover, hypercalcemia of malignancy, obesity or bone metastasis in a patient comprising administering to the patient with a therapeutically effective amount of the compound of  claim 1 .

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 1.42222
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12734224', '14647445', '14397200', '15580978', '14894817']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8045990459814459
- 35 USC 102 Novelty (BERT): 0.529080470844069
- Combined Prediction Score: 0.7770471884677083
- Mean Citation Score: 341.089354
- Max Citation Score: 366.94565
- Similarity Product: 177.51304777891488

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test